Company

TolerRx Inc.

TolerRx developed therapies for autoimmune diseases and immunotherapy.

About

TolerRx focused on developing treatments for autoimmune disorders and immunotherapy. The company was founded in 2000 and is based in Cambridge, US. It raised USD 1.5 mn in financing in December 2010.

4Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in